Biological Information
Background Information:
The SCF beta-TrCP1 complex is a multi-subunit E3 ubiquitin ligase belonging to the SCF (Skp1–Cullin–F-box) family. It consists of Skp1, Cul1, Rbx1 and the F-box substrate-recognition subunit beta-TrCP1. The complex serves as a critical regulator of multiple signaling pathways, including NF-kappaB, Wnt/beta-catenin, and DNA damage response networks. Through these roles, it influences cell proliferation, differentiation, immune activation, and oncogenesis. Beta-TrCP1 can act either as a tumor promoter (e.g. through degradation of I?B-alpha and activation of NF-kappa-B signaling) or as a tumor suppressor (e.g., by targeting beta-catenin or CDC25A). This context dependence makes it a nuanced target in cancer therapeutics.
Target Class:
Ubiquitination-related
Family:
F-box protein
Sub Family:
E3 Ligase
Protein Name:
beta-TrCP1
Protein Aliases:
beta-TRCP; E3RSIkappaB; BTRCP, FBW1A, FBXW1A (beta-TrCP1)
Accession Number:
NM_033637.2 (beta-TrCP1); NM_170679.2 (Skp1); NM_003592.2 (Cul1); NM_014248.2 (Rbx1)
UniProt Number:
Q9Y297 (beta-TrCP1)
Gene Name:
BTRC (beta-TrCP1)
Gene ID:
8945 (beta-TrCP1)
Gene Aliases:
FWD1; FBW1A; FBXW1; bTrCP; FBXW1A; bTrCP1; betaTrCP; BETA-TRCP (beta-TrCP1)
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Assay Measures:
ECL
Bioassay Data
Trademark Statement:
For Research Use Only
Clinical Relevance
Therapeutic Area:
Oncology